No racial disparities observed in IBD treatment among Medicaid patients

SAN ANTONIO — Researchers investigating racial disparities in health care found no significant difference in the use of biologics or other inflammatory bowel disease-specific treatments among black patients and white patients with the condition, according to an analysis of Medicaid data presented at the American College of Gastroenterology Annual Meeting.However, Edward Barnes, MD, assistant professor of medicine at the University of North Carolina at Chapel Hill, and colleagues found that black patients were more likely than white patients to receive combination therapy for Crohn’sRead More

Share on facebook
Share on twitter
Share on linkedin